epistem limited
epistem limited Company Information
Company Number
11031998
Next Accounts
Sep 2025
Industry
Research and experimental development on biotechnology
Shareholders
foresight regional investment lp
catherine booth
View AllGroup Structure
View All
Contact
Registered Address
the incubator building, grafton street, manchester, M13 9XX
Website
www.epistem.co.ukepistem limited Estimated Valuation
Pomanda estimates the enterprise value of EPISTEM LIMITED at £3.7m based on a Turnover of £2.4m and 1.53x industry multiple (adjusted for size and gross margin).
epistem limited Estimated Valuation
Pomanda estimates the enterprise value of EPISTEM LIMITED at £0 based on an EBITDA of £-843.2k and a 5.43x industry multiple (adjusted for size and gross margin).
epistem limited Estimated Valuation
Pomanda estimates the enterprise value of EPISTEM LIMITED at £0 based on Net Assets of £-3.1m and 1.89x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Epistem Limited Overview
Epistem Limited is a live company located in manchester, M13 9XX with a Companies House number of 11031998. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in October 2017, it's largest shareholder is foresight regional investment lp with a 58.4% stake. Epistem Limited is a young, small sized company, Pomanda has estimated its turnover at £2.4m with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Epistem Limited Health Check
Pomanda's financial health check has awarded Epistem Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 6 areas for improvement. Company Health Check FAQs
1 Strong
4 Regular
6 Weak
Size
annual sales of £2.4m, make it smaller than the average company (£4.4m)
- Epistem Limited
£4.4m - Industry AVG
Growth
3 year (CAGR) sales growth of -4%, show it is growing at a slower rate (13.9%)
- Epistem Limited
13.9% - Industry AVG
Production
with a gross margin of 54.5%, this company has a comparable cost of product (54.5%)
- Epistem Limited
54.5% - Industry AVG
Profitability
an operating margin of -39.3% make it less profitable than the average company (-5.7%)
- Epistem Limited
-5.7% - Industry AVG
Employees
with 21 employees, this is below the industry average (53)
21 - Epistem Limited
53 - Industry AVG
Pay Structure
on an average salary of £84.8k, the company has an equivalent pay structure (£84.8k)
- Epistem Limited
£84.8k - Industry AVG
Efficiency
resulting in sales per employee of £114.9k, this is equally as efficient (£131.4k)
- Epistem Limited
£131.4k - Industry AVG
Debtor Days
it gets paid by customers after 66 days, this is near the average (55 days)
- Epistem Limited
55 days - Industry AVG
Creditor Days
its suppliers are paid after 101 days, this is slower than average (63 days)
- Epistem Limited
63 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Epistem Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 6 weeks, this is less cash available to meet short term requirements (31 weeks)
6 weeks - Epistem Limited
31 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 312.6%, this is a higher level of debt than the average (51.6%)
312.6% - Epistem Limited
51.6% - Industry AVG
EPISTEM LIMITED financials
Epistem Limited's latest turnover from December 2023 is estimated at £2.4 million and the company has net assets of -£3.1 million. According to their latest financial statements, Epistem Limited has 21 employees and maintains cash reserves of £144.9 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|
| Turnover | ||||||
| Other Income Or Grants | ||||||
| Cost Of Sales | ||||||
| Gross Profit | ||||||
| Admin Expenses | ||||||
| Operating Profit | ||||||
| Interest Payable | ||||||
| Interest Receivable | ||||||
| Pre-Tax Profit | ||||||
| Tax | ||||||
| Profit After Tax | ||||||
| Dividends Paid | ||||||
| Retained Profit | ||||||
| Employee Costs | ||||||
| Number Of Employees | 21 | 35 | 38 | 33 | 28 | 29 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|
| Tangible Assets | 63,808 | 141,506 | 286,502 | 473,136 | 548,265 | 484,096 |
| Intangible Assets | 5,993 | 14,861 | 23,729 | 33,913 | 1,359,646 | 1,606,283 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 182,867 | 17,126 |
| Total Fixed Assets | 69,801 | 156,367 | 310,231 | 507,049 | 2,090,778 | 2,107,505 |
| Stock & work in progress | 0 | 12,904 | 157,387 | 21,000 | 14,745 | 0 |
| Trade Debtors | 442,195 | 291,807 | 839,742 | 350,775 | 545,409 | 520,713 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 787,259 | 726,395 | 294,442 | 306,226 | 327,273 | 321,148 |
| Cash | 144,936 | 714,031 | 1,511,077 | 2,000,654 | 616,244 | 808,678 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1,374,390 | 1,745,137 | 2,802,648 | 2,678,655 | 1,503,671 | 1,650,539 |
| total assets | 1,444,191 | 1,901,504 | 3,112,879 | 3,185,704 | 3,594,449 | 3,758,044 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 306,130 | 172,196 | 404,037 | 688,373 | 131,032 | 130,339 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 13,316 | 51,169 | 100,085 | 129,096 | 42,119 | 39,488 |
| other current liabilities | 862,451 | 620,991 | 1,365,585 | 1,028,285 | 636,603 | 576,696 |
| total current liabilities | 1,181,897 | 844,356 | 1,869,707 | 1,845,754 | 809,754 | 746,523 |
| loans | 0 | 0 | 0 | 0 | 0 | 1,899,972 |
| hp & lease commitments | 0 | 13,316 | 64,486 | 165,737 | 130,865 | 172,984 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 3,332,169 | 3,187,166 | 3,067,274 | 2,905,633 | 2,636,969 | 750,000 |
| provisions | 0 | 0 | 71,680 | 86,208 | 0 | 0 |
| total long term liabilities | 3,332,169 | 3,200,482 | 3,203,440 | 3,157,578 | 2,767,834 | 2,822,956 |
| total liabilities | 4,514,066 | 4,044,838 | 5,073,147 | 5,003,332 | 3,577,588 | 3,569,479 |
| net assets | -3,069,875 | -2,143,334 | -1,960,268 | -1,817,628 | 16,861 | 188,565 |
| total shareholders funds | -3,069,875 | -2,143,334 | -1,960,268 | -1,817,628 | 16,861 | 188,565 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | ||||||
| Depreciation | 97,033 | 183,638 | 226,561 | 206,633 | 144,349 | 58,994 |
| Amortisation | 8,868 | 8,868 | 101,184 | 0 | 294,927 | 146,025 |
| Tax | ||||||
| Stock | -12,904 | -144,483 | 136,387 | 6,255 | 14,745 | 0 |
| Debtors | 211,252 | -115,982 | 477,183 | -398,548 | 196,562 | 858,987 |
| Creditors | 133,934 | -231,841 | -284,336 | 557,341 | 693 | 130,339 |
| Accruals and Deferred Income | 241,460 | -744,594 | 337,300 | 391,682 | 59,907 | 576,696 |
| Deferred Taxes & Provisions | 0 | -71,680 | -14,528 | 86,208 | 0 | 0 |
| Cash flow from operations | ||||||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | -1,899,972 | 1,899,972 |
| Hire Purchase and Lease Commitments | -51,169 | -100,086 | -130,262 | 121,849 | -39,488 | 212,472 |
| other long term liabilities | 145,003 | 119,892 | 161,641 | 268,664 | 1,886,969 | 750,000 |
| share issue | ||||||
| interest | ||||||
| cash flow from financing | ||||||
| cash and cash equivalents | ||||||
| cash | -569,095 | -797,046 | -489,577 | 1,384,410 | -192,434 | 808,678 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -569,095 | -797,046 | -489,577 | 1,384,410 | -192,434 | 808,678 |
epistem limited Credit Report and Business Information
Epistem Limited Competitor Analysis
Perform a competitor analysis for epistem limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in M13 area or any other competitors across 12 key performance metrics.
epistem limited Ownership
EPISTEM LIMITED group structure
Epistem Limited has no subsidiary companies.
epistem limited directors
Epistem Limited currently has 5 directors. The longest serving directors include Dr Catherine Booth (Jan 2018) and Ms Julie Tudor (May 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Catherine Booth | United Kingdom | 59 years | Jan 2018 | - | Director |
| Ms Julie Tudor | United Kingdom | 52 years | May 2018 | - | Director |
| Mr Richard Ralph | England | 32 years | Nov 2023 | - | Director |
| Mr Andrew Milnes | 61 years | Nov 2023 | - | Director | |
| Mr Anthony King | United Kingdom | 67 years | Oct 2024 | - | Director |
P&L
December 2023turnover
2.4m
-11%
operating profit
-949.1k
0%
gross margin
54.6%
+1.85%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-3.1m
+0.43%
total assets
1.4m
-0.24%
cash
144.9k
-0.8%
net assets
Total assets minus all liabilities
epistem limited company details
company number
11031998
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
October 2017
age
8
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
epistem 2 limited (June 2018)
accountant
MHA MOORE AND SMALLEY
auditor
-
address
the incubator building, grafton street, manchester, M13 9XX
Bank
-
Legal Advisor
-
epistem limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to epistem limited. Currently there are 3 open charges and 0 have been satisfied in the past.
epistem limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for EPISTEM LIMITED. This can take several minutes, an email will notify you when this has completed.
epistem limited Companies House Filings - See Documents
| date | description | view/download |
|---|
